(Press-News.org) University of Washington researchers have discovered they can detect atomic "breathing," or the mechanical vibration between two layers of atoms, by observing the type of light those atoms emitted when stimulated by a laser. The sound of this atomic "breath" could help researchers encode and transmit quantum information.
The researchers also developed a device that could serve as a new type of building block for quantum technologies, which are widely anticipated to have many future applications in fields such as computing, communications and sensor development.
The researchers published these findings June 1 in Nature Nanotechnology.
"This is a new, atomic-scale platform, using what the scientific community calls 'optomechanics,' in which light and mechanical motions are intrinsically coupled together," said senior author Mo Li, a UW professor of both electrical and computer engineering and physics. "It provides a new type of involved quantum effect that can be utilized to control single photons running through integrated optical circuits for many applications."
Previously, the team had studied a quantum-level quasiparticle called an "exciton." Information can be encoded into an exciton and then released in the form of a photon — a tiny particle of energy considered to be the quantum unit of light. Quantum properties of each photon emitted — such as the photon’s polarization, wavelength and/or emission timing — can function as a quantum bit of information, or "qubit," for quantum computing and communication. And because this qubit is carried by a photon, it travels at the speed of light.
"The bird’s-eye view of this research is that to feasibly have a quantum network, we need to have ways of reliably creating, operating on, storing and transmitting qubits," said lead author Adina Ripin, a UW doctoral student of physics. "Photons are a natural choice for transmitting this quantum information because optical fibers enable us to transport photons long distances at high speeds, with low losses of energy or information."
The researchers were working with excitons in order to create a single photon emitter, or "quantum emitter," which is a critical component for quantum technologies based on light and optics. To do this, the team placed two thin layers of tungsten and selenium atoms, known as tungsten diselenide, on top of each other.
When the researchers applied a precise pulse of laser light, they knocked a tungsten diselenide atom’s electron away from the nucleus, which generated an exciton quasiparticle. Each exciton consisted of a negatively charged electron on one layer of the tungsten diselenide and a positively charged hole where the electron used to be on the other layer. And because opposite charges attract each other, the electron and the hole in each exciton were tightly bonded to each other. After a short moment, as the electron dropped back into the hole it previously occupied, the exciton emitted a single photon encoded with quantum information — producing the quantum emitter the team sought to create.
But the team discovered that the tungsten diselenide atoms were emitting another type of quasiparticle, known as a phonon. Phonons are a product of atomic vibration, which is similar to breathing. Here, the two atomic layers of the tungsten diselenide acted like tiny drumheads vibrating relative to each other, which generated phonons. This is the first time phonons have ever been observed in a single photon emitter in this type of two-dimensional atomic system.
When the researchers measured the spectrum of the emitted light, they noticed several equally spaced peaks. Every single photon emitted by an exciton was coupled with one or more phonons. This is somewhat akin to climbing a quantum energy ladder one rung at a time, and on the spectrum, these energy spikes were represented visually by the equally spaced peaks.
"A phonon is the natural quantum vibration of the tungsten diselenide material, and it has the effect of vertically stretching the exciton electron-hole pair sitting in the two layers," said Li, who is also is a member of the steering committee for the UW’s QuantumX, and is a faculty member of the Institute for Nano-Engineered Systems. "This has a remarkably strong effect on the optical properties of the photon emitted by the exciton that has never been reported before."
The researchers were curious if they could harness the phonons for quantum technology. They applied electrical voltage and saw that they could vary the interaction energy of the associated phonons and emitted photons. These variations were measurable and controllable in ways relevant to encoding quantum information into a single photon emission. And this was all accomplished in one integrated system — a device that involved only a small number of atoms.
Next the team plans to build a waveguide — fibers on a chip that catch single photon emissions and direct them where they need to go — and then scale up the system. Instead of controlling only one quantum emitter at a time, the team wants to be able to control multiple emitters and their associated phonon states. This will enable the quantum emitters to "talk" to each other, a step toward building a solid base for quantum circuitry.
"Our overarching goal is to create an integrated system with quantum emitters that can use single photons running through optical circuits and the newly discovered phonons to do quantum computing and quantum sensing," Li said. "This advance certainly will contribute to that effort, and it helps to further develop quantum computing which, in the future, will have many applications."
Other co-authors are Ruoming Peng, Xiaowei Zhang, Srivatsa Chakravarthi, Minhao He, Xiaodong Xu, Kai-Mei Fu and Ting Cao. This research is funded by the National Science Foundation.
For more information, contact Li at moli96@uw.edu.
END
The 'breath' between atoms — a new building block for quantum technology
2023-06-01
ELSE PRESS RELEASES FROM THIS DATE:
CHOP researchers use “deep sequencing” to identify several previously undescribed genetic variants in vascular anomalies
2023-06-01
Philadelphia, June 1, 2023 – Researchers from Children’s Hospital of Philadelphia (CHOP) recently discovered that extremely thorough “deep sequencing” of the genome in tissue samples and cell-free DNA of patients with potentially life-threatening vascular anomalies captured several genetic variants related to disease that were not captured with conventional genetic sequencing methods. More than 60% of patients saw an improvement in their condition after being placed on targeted therapies related to these newly found genetic variants. The findings were published today in the journal Nature Medicine.
Vascular ...
Quantifying mangroves’ value as a climate solution and economic engine
2023-06-01
A tiny Central American country is charting a path to slowing climate change, while boosting the economy and making communities safer. A new Stanford-led study quantifies the value of Belize’s coastal mangrove forests in terms of how much carbon they can hold, the value they can add to tourism and fisheries, and the protection they can provide against coastal storms and other risks. Importantly, the findings, published June 1 in Nature Ecology and Evolution, have already provided a basis for Belize’s commitment to protect or restore additional mangrove forests totaling an area about the size ...
Smart thermometer–based participatory surveillance to discern the role of children in household viral transmission during pandemic
2023-06-01
About The Study: In this study using smart thermometers to measure within-household transmission at a national scale, researchers discerned an important role for children in the spread of viral infection within households during the COVID-19 pandemic, heightened when schools were in session, supporting a role for school attendance in COVID-19 spread.
Authors: Kenneth D. Mandl, M.D., M.P.H., of Boston Children’s Hospital, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.16190)
Editor’s ...
Global, race-neutral reference equations and pulmonary function test interpretation
2023-06-01
About The Study: The use of race-neutral reference equations to interpret pulmonary function tests resulted in a significant increase in the number of Black individuals with respiratory impairments along with a significant increase in the severity of the identified impairments. More work is needed to quantify the effect these reference equations would have on diagnosis, referral, and treatment patterns.
Authors: Alexander T. Moffett, M.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.
To access the embargoed study: Visit our For The Media website ...
Efficacy, safety of atropine for the treatment of pediatric nearsightedness progression over 3 years
2023-06-01
About The Study: The efficacy and safety observed in this randomized clinical trial suggest that low-dose atropine may provide a treatment option for childhood myopia progression.
Authors: Karla Zadnik, O.D., Ph.D., of the Ohio State University College of Optometry in Columbus, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaophthalmol.2023.2097)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial ...
Personalizing prostate cancer screening may improve the accuracy of detection
2023-06-01
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer, according to a multi-center study led by UC San Francisco and Stanford University.
In a study publishing June 1, 2023 in Nature Medicine, UCSF researchers and their collaborators conducted a large genome-wide association study of PSA in more than 95,000 men without diagnosed prostate cancer, which identified over 80 novel PSA-associated variants. They set ...
NIH’s ComboMATCH initiative will test new drug combinations guided by tumor biology
2023-06-01
The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations. Known as the Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH), the initiative is the largest of its kind to test combinations of cancer drugs guided by tumor biology. The endeavor aims to identify promising treatments that can advance to larger, more definitive clinical ...
High-resolution images reveal workings of a bacterial RNA riboswitch, a promising new target for antibiotics
2023-06-01
Image
To prevent a global health crisis, scientists around the world are searching for ways to fight bacteria that can evade the current arsenal of antibiotics.
A promising target for new and improved antibiotics are riboswitches, small stretches of RNA that regulate a process necessary for the production of proteins by the bacterial cell. Riboswitches are found almost exclusively in bacteria and could be targeted with antibiotics so that animals or humans are unaffected. With a full understanding of how riboswitches work, researchers may be able to develop drugs that disrupt the cellular machinery ...
University College Dublin researcher receives ERC funding to unlock insights into pig-to-human heart transplants
2023-06-01
Thursday 1st June: Dr Philip Cardiff, Associate Professor at University College Dublin's School of Mechanical and Materials Engineering, has received a European Research Council (ERC) Consolidator grant of €2 million for his 5-year project XenoSim. With the support of this award, Dr Cardiff will develop advanced computational techniques that can provide unprecedented insights into the cutting-edge realm of pig-to-human heart transplants
ERC Consolidator Grants are awarded to help excellent scientists, ...
SISAQOL-IMI: Setting standards for the use of patient-reported outcome data in cancer trials
2023-06-01
Brussels, 1 June 2023 – Today, the European Organisation for Research and Treatment of Cancer (EORTC) is excited to share the publication of the first consensus paper by the SISAQOL-IMI Consortium1. The paper provides an overview of the stakeholders’ views on the need for SISAQOL-IMI and the agreed priority set of patient-reported outcome (PRO) objectives that the Consortium will produce international consensus-based recommendations on.
The Setting International Standards in Analysing ...